[Thrombophlebitis of the cavernous sinus and staphylococcal pleuropulmonitis in the newborn; treatment with antibiotics and anticoagulants].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D002426:Cavernous Sinus; D002648:Child / Q000472:pathogenicity; D003879:Dermatologic Agents; D006801:Humans; D007223:Infant / Q000472:pathogenicity; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008837:Micrococcus / Q000472:pathogenicity*; D011001:Pleuropneumonia; D012851:Sinus Thrombosis, Intracranial; D013924:Thrombophlebitis
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D003879:Dermatologic Agents
ANTIBIOTICS/therapeutic use; ANTICOAGULANTS/therapeutic use; INFANT, NEWBORN/diseases; MICROCOCCAL INFECTIONS/in infant and child; PLEUROPNEUMONIA/in infant and child; SINUS THROMBOSIS/in infant and child
Tromboflebite del seno cavernoso e pleuropolmonite da stafilococco in neonato; trattamento con antibiotici ed anticoagulanti.